TB-500 is a seven-amino-acid fragment based on thymosin beta-4. Laboratory research has explored actin binding and cell migration, but FDA has identified no human exposure data for TB-500 itself. Available by prescription only after provider review.
From $199 first month
Mechanism education without turning preclinical findings into promises.
TB-500 is an acetylated seven-amino-acid fragment corresponding to residues 17 to 23 of thymosin beta-4. TB-500 and full-length thymosin beta-4 are not the same substance.
Research on thymosin beta-4 and its fragments has explored actin binding and cell-migration pathways. Findings from the full-length protein or animal models cannot be assumed to apply to TB-500 use in humans.
FDA identified no clinical studies or human exposure data for TB-500 by any route. Human effectiveness, dosing, interactions, and long-term safety are unknown.
A licensed provider reviews your history and medications before determining whether this compounded injectable option is appropriate and how it should be used.
Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.
When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.
Each product page separates mechanism research from human evidence so the unknowns stay visible.
Message your care team with questions about your protocol, refills, or side effects.
Get started in 4 simple steps. No office visits required.
A 5-minute online health questionnaire, no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose questions and refills are handled online.
TB-500 has laboratory and animal research context, but FDA identified no human exposure data. Full-length thymosin beta-4 findings are not interchangeable with TB-500 evidence.
No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.
Complete the online assessment. A licensed provider reviews your medical history, medications, and goals before deciding whether to prescribe.
Current pricing is shown on this page when a customer offer exists. Your provider-directed protocol and any additional details are confirmed during assessment and review.
Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.
Start Assessment